Enduring Material

New Onset Type I IDDM Following Covid-19 Infection in a Pediatric Patient
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
Munson Healthcare

1105 Sixth Street
Traverse City, MI 49684
General Information
Monday, August 22, 2022 - Friday, August 22, 2025
60 minutes
Munson Healthcare
Virtual Conference Room
Pediatric Case Conference: Pediatric DKA Protocol
Munson Healthcare
Presentations and Speakers
New Onset Type I IDDM Following Covid-19 Infection in a Pediatric Patient
  • Amanda Jackson-Morgan, DO
  • Joseph Rawlin, DO - Munson Family Practice
  • Jacques Burgess, MD
  • Nader Kasim, MD - Helen DeVos Children's Hospital
Available Credits/Points
  • Munson Healthcare designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The Munson Healthcare designates this enduring material for a maximum of 1 Credit(s) AOA Category 1-B. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A 60-minute recorded webinar on the topic of new onset Type I IDDM in children. It will include a case discussion as well as suggestions for future cases. It will also include a discussion of the impact of the COVID-19 pandemic on rates of pediatric diabetes and an overview of the new MHC pediatric DKA protocol.
  • Pediatrics - 1 Hour(s)
Disclosure Statements
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Munson Healthcare will implement mechanisms to identify and mitigate relevant financial relationships with ineligible companies for all individuals in a position to control content of this activity.
Speakers:
Jacques Burgess, MD, Amanda Jackson-Morgan, DO, and J. William Rawlin, DO have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Nader Kasim, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Provention Bio - Advisory Committee Member - Relationship Has Not Ended
  • Cystic Fibrosis Foundation - Contracted Research - Relationship Has Not Ended
Any financial relationship that was found to be relevant has been mitigated.

Planners and other Administrative Support:
Jacques Burgess, MD and Katie West, RN have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Accreditation Statement
  • Munson Healthcare is accredited by the Michigan State Medical Society to provide continuing medical education for physicians.
Test Information
80 %
9/19/2022
Continue to Enduring Material